Who we are

Hikma puts better health within reach, every day. We create high-quality medicines and make them accessible to the people who need them, helping to shape a healthier world that enriches all our communities.

History

Founded in 1978, Hikma is a global pharmaceutical company manufacturing and supplying high-quality generics, branded generics and specialty medicines across North America, Europe and the MENA region. 

 

Open
Purpose
We put better health within reach, every day. We do this by making high-quality medicines accessible to the people who depend on them.
Open
Strategy

We aim to deliver consistent and profitable growth by building a leading generics and speciality pharmaceutical company.

Open
Culture

We are one Hikma living a culture of progress and belonging, shaped by our three values: innovation, care and collaboration. 

 

Open

Leadership that drives progress

Leadership

As global health needs evolve, our purpose continues to guide our strategy and ambition almost 50 years later. We are strengthening our capabilities, expanding our portfolio, and investing in our future, so we can continue to make a meaningful difference. 

Our purpose is a promise to deliver high-quality medicines, to act with as a responsible business, and to help build a healthier future for all. 

Said Darwazah

Chief Executive Officer

Hikma at a glance

Our strategy

825+ products

Across Injectables, Branded and Hikma Rx

29 manufacturing plants

Across North America, EU and MENA 

3 R&D hubs

US, Jordan and Croatia

13 US FDA‑inspected facilities 

12 EMA‑inspected facilities 

9,400 empowered employees

Our responsibility framework guides how we ensure patients across the US, Canada, Europe and the MENA region have access to high-quality medicines.

Acting responsibly

Responsibility

We act responsibly by advancing health and wellbeing, empowering our people, protecting the environment, and building trust through quality in everything we do. We work in line with the standards of regulators across our markets, and we partner with healthcare providers, patient groups and communities to widen access to medicines.

Latest news

Featured

Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes

Press Release, Financial Results
Related content

Explore more